nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
|
Kim, Richard |
|
|
91 |
4 |
p. 291-300 |
artikel |
2 |
A prospective feasibility study of uracil–tegafur and leucovorin as adjuvant chemotherapy for patients aged ≥ 80 years after curative resection of colorectal cancer, the HiSCO-03 study
|
Okuda, Hiroshi |
|
|
91 |
4 |
p. 317-324 |
artikel |
3 |
A three-marker signature identifies senescence in human breast cancer exposed to neoadjuvant chemotherapy
|
El-Sadoni, Mohammed |
|
|
91 |
4 |
p. 345-360 |
artikel |
4 |
Correction to: A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
|
Kim, Richard |
|
|
91 |
4 |
p. 301 |
artikel |
5 |
Emetine, a small molecule natural product, displays potent anti-gastric cancer activity via regulation of multiple signaling pathways
|
Peng, Xuerun |
|
|
91 |
4 |
p. 303-315 |
artikel |
6 |
Impact of pre-hydration duration on high-dose methotrexate induced nephrotoxicity in childhood acute lymphoblastic leukaemia in resource constraint centers: a randomized crossover study
|
Khera, Sanjeev |
|
|
91 |
4 |
p. 331-336 |
artikel |
7 |
Olaparib in an ovarian cancer patient with end-stage renal disease and hemodialysis
|
Baum, Joanna |
|
|
91 |
4 |
p. 325-330 |
artikel |
8 |
Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma
|
Legros, Laurence |
|
|
91 |
4 |
p. 337-344 |
artikel |